Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rflrob
    Member
    • May 2010
    • 50

    #1

    Comparing FPKMs of a subset to the whole

    I have several Illumina RNA-seq libraries that, I believe, represent the various components of a previous dataset that was not able to dissect their sample quite as finely. If I want to compare my data to theirs, what's the philosophically correct way to combine the FPKMs? I can come up with arguments for either a weighted sum or a weighted average (I'm leaning towards the latter, since FPKM is analogous to a concentration).

    And having chosen one of those, what's the best way to determine the weights? I can make an estimate of the initial amounts of each sample in ng of total RNA based on a spike-in control, but the measurements on those are noisy enough that I'm a little skeptical.

    One thing that troubles me is that the FPKM values for various ubiquitous genes (actins, at the moment, though I can certainly check others) vary across the samples, and vary roughly consistently across samples, so I'd like to correct based on a set of things that I can argue are uniformly expressed, but I'm a little worried that's going to come off as sketchy. Thoughts?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...